newsfilter
← Latest News
Business Wire·

enGene Reports Full Year 2025 Financial Results and Provides Business Update

Completed enrollment in LEGEND's pivotal cohort with 125 patients in high-risk, BCG-unresponsive NMIBC with carcinoma in situ Reported preliminary 6-month complete response rate (62%) in pivotal cohort patients